The treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Progress in clinical and biological research

• Publication date

  1997-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(01)64806-7PMID 2780667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• alpha-Interferon and interleukin-2 in renal cell carcinoma: studies in nonhospitalized patients.

  1991cited by this paper
• Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases.

  1991cited by this paper
• Treatment of metastatic renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.

  1991cited by this paper
• Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma.

  1990cited by this paper
• Cimetidine: An Immunomodulator

  1990cited by this paper
• An assessment of the current use of human interferons in therapy of urological cancers.

  1989cited by this paper
• Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.

  1987cited by this paper
• Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials

  1986cited by this paper
• [The treatment of metastatic renal cell carcinoma with human lymphoblastoid alpha-interferon].

  1986cited by this paper
• Metastatic malignant melanoma: Regression induced by combined treatment with interferon [HuIFN‐α(Le)] and cimetidine

  1983cited by this paper
• Renal cell carcinoma: long-term survival and late recurrence.

  1981cited by this paper
• Cell surface antigens of human renal cancer defined by autologous typing

  1979cited by this paper
• The natural history of metastatic renal cell carcinoma: a computer analysis.

  1978cited by this paper

• Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets

  2021cites this paper
• Old wine in new bottles: Drug repurposing in oncology.

  2019cites this paper
• Thalidomide Embryopathy - Orthopaedic aspects. Degenerative changes and quality of life at age 45

  2016cites this paper
• Urologic cancer in Japan: role of Japan at the frontier of issues in Asia.

  2016cites this paper
• Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent

  2014cites this paper
• Phase‐II trial of combination treatment of interferon‐α, cimetidine, cyclooxygenase‐2 inhibitor and renin‐angiotensin‐system inhibitor (I‐CCA therapy) for advanced renal cell carcinoma

  2011cites this paper
• Cimetidine: an anticancer drug?

  2011cites this paper
• Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review).

  2006cites this paper
• Positive correlation between sialyl Lewis X expression and pathologic findings in renal cell carcinoma.

  2005cites this paper
• Novel treatments for metastatic renal cell carcinoma.

  2005cites this paper
• Current treatment of renal cell carcinoma.

  2004cites this paper
• Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma.

  2002cites this paper
• Gamma‐knife radiosurgery for brain metastasis of renal cell carcinoma: Results in 42 patients

  2002cites this paper
• [An investigation of serum soluble interferon receptor levels in patients with renal cell carcinoma].

  2000cites this paper
• Pharmacokinetics of Natural Human IFN-α in Hemodialysis Patients

  1999cites this paper
• Preliminary results of the alternating administration of natural interferon‐α and recombinant interferon‐γ for metastatic renal cell carcinoma

  1999cites this paper
• Does Cimetidine Improve Prospects for Cancer Patients?

  1999cites this paper